Bicara Therapeutics BCAX Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months) at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Bicara Therapeutics's available-for-sale debt securities - unrealized loss position (>=12 months)?
- Bicara Therapeutics (BCAX) reported available-for-sale debt securities - unrealized loss position (>=12 months) of $0 in Q1 2026.